What is distal subungual onychomycosis?

Distal subungual onychomycosis (DSO) is the most common clinical form of fungal nail infection, particularly affecting toenails. It begins at the distal (far) edge or lateral margins of the nail plate and gradually progresses proximally beneath the nail. The infection is typically caused by dermatophytes—most frequently Trichophyton rubrum—though non-dermatophyte molds and yeasts such as Candida species may also be implicated, especially in immunocompromised individuals or those with chronic moisture exposure.

Clinically, DSO presents with subungual hyperkeratosis (thickened, crumbly debris accumulating under the nail), onycholysis (separation of the nail plate from the underlying nail bed), discoloration (often yellow, brown, or opaque white), and progressive nail dystrophy—including brittleness, ridging, and eventual nail plate destruction. Unlike superficial white onychomycosis, which involves only the dorsal surface, DSO involves the nail bed and matrix to varying degrees, making it more challenging to treat and more likely to recur.

Diagnosis requires confirmation via potassium hydroxide (KOH) preparation, fungal culture, or polymerase chain reaction (PCR) testing—clinical appearance alone is insufficient due to overlap with psoriasis, lichen planus, trauma-induced changes, and other nail dystrophies. Treatment typically involves oral antifungal agents such as terbinafine or itraconazole, selected based on fungal species, hepatic function, drug interactions, and patient comorbidities. Topical therapies (e.g., ciclopirox or efinaconazole) may be considered for mild, limited disease but have lower efficacy in DSO due to poor drug penetration into the subungual space. Adjunctive measures—including nail debridement, footwear hygiene, and management of predisposing factors like tinea pedis—are essential components of comprehensive care.